Credit Suisse Ag Xenon Pharmaceuticals Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 85,339 shares of XENE stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,339

Previous 81,795 4.33%

Holding current value

$3.27 Million

Previous $3.77 Million 2.5%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$42.66 - $50.04 $151,187 - $177,341	3,544 Added 4.33%	85,339 $3.67 Million
Q4 2023 Feb 08, 2024	BUY	$28.7 - $46.46 $465,198 - $753,070	16,209 Added 24.71%	81,795 $3.77 Million
Q3 2023 Nov 13, 2023	SELL	$34.16 - $39.73 $8,232 - $9,574	-241 Reduced 0.37%	65,586 $2.24 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $270,253 - $337,739	7,757 Added 13.36%	65,827 $2.53 Million
Q1 2023 May 10, 2023	BUY	$33.46 - $40.35 $109,782 - $132,388	3,281 Added 5.99%	58,070 $2.08 Million
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $368,156 - $439,092	11,136 Added 25.51%	54,789 $2.16 Million
Q3 2022 Nov 10, 2022	BUY	$30.79 - $39.82 $322,340 - $416,875	10,469 Added 31.55%	43,653 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $77,184 - $106,675	3,034 Added 10.06%	33,184 $1.01 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $131,622 - $173,799	5,246 Added 21.06%	30,150 $922,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $96,813 - $219,692	6,206 Added 33.19%	24,904 $777,000
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $1,203 - $1,575	81 Added 0.44%	18,698 $286,000
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $92,017 - $109,480	-5,474 Reduced 22.72%	18,617 $346,000
Q1 2021 May 14, 2021	BUY	$13.65 - $21.31 $76,617 - $119,613	5,613 Added 30.38%	24,091 $432,000
Q4 2020 Feb 12, 2021	BUY	$9.49 - $16.04 $45,485 - $76,879	4,793 Added 35.02%	18,478 $283,000
Q2 2020 Aug 12, 2020	BUY	$10.21 - $14.9 $139,723 - $203,906	13,685 New	13,685 $172,000
Q3 2019 Nov 12, 2019	SELL	$8.74 - $10.51 $126,834 - $152,521	-14,512 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.51 - $10.75 $123,497 - $156,004	14,512 New	14,512 $143,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account